GeneBioTech Co. ,Ltd (KOSDAQ:086060)
South Korea
· Delayed Price · Currency is KRW 5,130.00
-50.00 (-0.97%)
At close: Mar 6, 2026
GeneBioTech Co. ,Ltd Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 5, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 43,311 | 28,329 | 37,542 | 34,356 | 45,119 | 49,511 | Upgrade
|
| Market Cap Growth | 54.29% | -24.54% | 9.27% | -23.86% | -8.87% | 2.31% | Upgrade
|
| Enterprise Value | 35,299 | 19,776 | 30,940 | 31,105 | 35,590 | 41,859 | Upgrade
|
| Last Close Price | 5030.00 | 3249.43 | 4306.24 | 3940.80 | 5175.39 | 5679.10 | Upgrade
|
| PE Ratio | 11.77 | 9.89 | 14.49 | 22.55 | - | - | Upgrade
|
| PS Ratio | 0.47 | 0.34 | 0.47 | 0.42 | 0.72 | 0.84 | Upgrade
|
| PB Ratio | 0.80 | 0.56 | 0.78 | 0.75 | 1.03 | 0.98 | Upgrade
|
| P/TBV Ratio | 0.81 | 0.56 | 0.79 | 0.77 | 1.05 | 1.12 | Upgrade
|
| P/FCF Ratio | 30.37 | - | 5.49 | - | - | - | Upgrade
|
| P/OCF Ratio | 7.66 | - | 5.10 | - | - | 19.87 | Upgrade
|
| EV/Sales Ratio | 0.38 | 0.24 | 0.39 | 0.38 | 0.57 | 0.71 | Upgrade
|
| EV/EBITDA Ratio | 6.08 | 3.79 | 5.83 | 10.94 | 44.98 | 44.05 | Upgrade
|
| EV/EBIT Ratio | 7.97 | 5.15 | 7.79 | 19.98 | - | - | Upgrade
|
| EV/FCF Ratio | 24.75 | - | 4.52 | - | - | - | Upgrade
|
| Debt / Equity Ratio | 0.26 | 0.31 | 0.26 | 0.28 | 0.23 | 0.11 | Upgrade
|
| Debt / EBITDA Ratio | 2.43 | 3.05 | 2.35 | 4.58 | 13.02 | 5.90 | Upgrade
|
| Debt / FCF Ratio | 9.90 | - | 1.83 | - | - | - | Upgrade
|
| Net Debt / Equity Ratio | -0.15 | -0.15 | -0.20 | -0.07 | -0.17 | -0.43 | Upgrade
|
| Net Debt / EBITDA Ratio | -1.38 | -1.44 | -1.79 | -1.08 | -9.46 | -22.93 | Upgrade
|
| Net Debt / FCF Ratio | -5.62 | 4.81 | -1.39 | 0.63 | 1.29 | 11.50 | Upgrade
|
| Asset Turnover | 1.25 | 1.20 | 1.22 | 1.33 | 1.03 | 0.91 | Upgrade
|
| Inventory Turnover | 4.91 | 4.37 | 4.35 | 4.97 | 4.59 | 4.69 | Upgrade
|
| Quick Ratio | 2.44 | 2.02 | 2.33 | 1.91 | 1.99 | 4.44 | Upgrade
|
| Current Ratio | 3.53 | 3.04 | 3.40 | 2.91 | 2.98 | 5.92 | Upgrade
|
| Return on Equity (ROE) | 7.05% | 5.77% | 5.51% | 3.40% | -1.03% | -0.13% | Upgrade
|
| Return on Assets (ROA) | 3.77% | 3.48% | 3.82% | 1.56% | -0.46% | -1.05% | Upgrade
|
| Return on Invested Capital (ROIC) | 7.71% | 7.65% | 7.49% | 3.30% | -1.39% | -3.41% | Upgrade
|
| Return on Capital Employed (ROCE) | 7.40% | 7.20% | 7.70% | 3.20% | -1.00% | -2.00% | Upgrade
|
| Earnings Yield | 8.50% | 10.11% | 6.90% | 4.43% | -1.07% | -4.73% | Upgrade
|
| FCF Yield | 3.29% | -5.52% | 18.21% | -14.07% | -12.89% | -3.83% | Upgrade
|
| Dividend Yield | 0.97% | - | - | - | - | 0.53% | Upgrade
|
| Buyback Yield / Dilution | -0.03% | - | - | - | - | - | Upgrade
|
| Total Shareholder Return | 0.94% | - | - | - | - | 0.53% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.